Tag: Astrazeneca
AstraZeneca: acquisition of Fusion in precision oncology
(CercleFinance.com) – AstraZeneca announced on Tuesday that it would take control of the Canadian company Fusion Pharmaceuticals, specializing in precision cancer drugs, in a transaction worth up to $2.4 billion.…
AstraZeneca buys French biotech Amolyt Pharma for near-record sum of $1 billion
In the history of French biotech, Amolyt Pharma will undoubtedly feature prominently in the pantheon of French successes. The company, based in Ecully, in the Lyon metropolis, has just announced,…
AstraZeneca: Preparing for future pandemics in UK
(CercleFinance.com) – AstraZeneca plans to invest £650 million in the United Kingdom to prepare the country for future pandemics, the British government announced on Wednesday. The biopharmaceutical group notably intends…
AstraZeneca: EMA validates Dato-DXd for two cancers
(CercleFinance.com) – AstraZeneca announced Monday that the European Medicines Agency (EMA) had validated its application for marketing authorization as part of the evaluation of Dato-DXd in two types of cancer.…
AstraZeneca: the CHMP issues a favorable opinion in PNH
(CercleFinance.com) – AstraZeneca announced Monday that the CHMP had issued a favorable opinion with a view to granting marketing authorization in the European Union for Voydeya, its treatment for paroxysmal…
AstraZeneca: $5 billion bond issue
(CercleFinance.com) – AstraZeneca launched on Thursday the issue of a bond of five billion dollars in four tranches, an operation intended to allow it to refinance its debt. The operation…
AstraZeneca: Successfully completes the acquisition of Icosavax
(CercleFinance.com) – AstraZeneca announced today that it has successfully completed the acquisition of Icosavax, an American biopharmaceutical company focused on the development of ‘high-potential differentiated vaccines’. Following this acquisition, Icosavax…
AstraZeneca buys American biotech Icosavax, vaccine specialist
(AOF) – AstraZeneca today announced the successful completion of the acquisition of Icosavax, a US clinical-stage biopharmaceutical company focused on the development of high-potential differentiated vaccines using an innovative virus-like…
AstraZeneca: ‘major breakthrough’ in lung cancer
(CercleFinance.com) – AstraZeneca reports that the results of a phase III trial showed that Tagrisso (osimertinib) provided a ‘statistically and clinically significant’ improvement in progression-free survival (PFS) in patients with…
AstraZeneca: FDA approves Tagrisso against lung cancer – 02/19/2024 at 11:06
(AOF) – AstraZeneca announces that its product Tagrisso (osimertinib) combined with chemotherapy has been approved in the United States for the treatment of adult patients with locally advanced or metastatic…
AstraZeneca: New decline after two negative analyzes
(CercleFinance.com) – The stock is down almost 2% today on the London Stock Exchange after two negative analyses. UBS confirms its sell advice on the stock with a target lowered…
AstraZeneca forecasts an increase in its results in 2024
Published on 02/08/2024 at 08:44 a.m. Feb 8 (Reuters) – AstraZeneca said on Thursday it expects revenue and profit to rise in 2024,…